HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prognostic factors in anal carcinoma.

Abstract
This study was performed to examine if commonly recorded parameters are of prognostic importance for patients with squamous cell carcinoma of the anal canal. A total of 77 patients received combined chemoradiotherapy and were followed at regular intervals after treatment. Age, sex, performance status, tumour stage, histopathological differentiation and grade, were not found to be of prognostic importance. Most blood tests did not correlate with prognosis, although elevated serum alkaline phosphatase (ALP) and lactate dehydrogenase (LD) proved to be unfavourable prognostic factors. In the present study serum ALP and LD were the only parameters that significantly correlated with development of distant metastases during follow-up.
AuthorsG Tanum, E Hannisdal, B Stenwig
JournalOncology (Oncology) Vol. 51 Issue 1 Pg. 22-4 ( 1994) ISSN: 0030-2414 [Print] Switzerland
PMID8265098 (Publication Type: Journal Article)
Chemical References
  • Mitomycin
  • Fluorouracil
Topics
  • Adult
  • Age Factors
  • Aged
  • Aged, 80 and over
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Anus Neoplasms (mortality, pathology, radiotherapy, therapy)
  • Carcinoma, Squamous Cell (mortality, pathology, radiotherapy, therapy)
  • Female
  • Fluorouracil (administration & dosage)
  • Humans
  • Lymphatic Metastasis
  • Male
  • Middle Aged
  • Mitomycin (administration & dosage)
  • Neoplasm Staging
  • Prognosis
  • Retrospective Studies
  • Sex Factors
  • Survival Analysis
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: